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Influence of short-term training on functional capacity
and (anti-)inflammatory immune signalling in acute
hospitalization
Introduction
It has been shown that 7 days of in-hospital inactivity induces
a rapid decline (>10%) in total lean leg mass in healthy older
adults,1 and loss of muscle mass has been associated with a
lower likelihood of survival after hospitalization in older
patients.2 In this regard, chronic, low-grade inflammation is
a hallmark of aging and is associated with changes in body
composition and declining physical function, making older
adults even more vulnerable to the negative impact of
hospitalization.2 The release of muscle-derived myokines is
responsible for many of the beneficial effects of exercise in
older adults, particularly by promoting a healthy anti-inflam-
matory milieu3 and may thus complement the anti-inflamma-
tory and analgesic actions of medications.
To investigate the influence of exercise on inflammatory
signalling,3 we performed cytokine array profiling in human
serum to identify inflammatory cytokines produced after a
3 day in-hospital intervention including individualized moder-
ate-intensity resistance, balance, and walking exercises vs.
medical usual-care for acute hospitalization in very elderly
patients.
The study was conducted at the Department of Geriat-
rics, Complejo Hospitalario de Navarra (Research Ethics
Committee ID Pyto2018/7, No. 264, dated 15 April 2018).
All patients or their legal representatives provided written
consent. The usual-care group (n = 20) received habitual
hospital care, which included physical rehabilitation when
needed. For the intervention group (n = 18), exercise
training was programmed in two daily sessions (morning
and evening) of 20 min duration during five to seven con-
secutive days (including weekends) supervised by a quali-
fied fitness specialist.4
Quantification of 80 analytes in EDTA plasma samples was
performed at Cytokine Array–Human Cytokine Antibody
Array (ABCAM Membrane, 80 Targets # ab133998) (Myriad
RBM, Austin, USA). Medical and functional characteristics in
each group were reported as the estimated margin of the
mean, as assessed by 95% confidence intervals using a two-
factor [group (control or exercise) × time (baseline and after
intervention)] repeated-measures analysis of covariance
(ANCOVA) with the pre-test used as a covariate in the
model.3 We used relative treatment effect (RTE) for exercise
cytokine response. RTE can be briefly interpreted as the ef-
fects through the normalized data distribution (ranges from
0 to 1). Correlation coefficients (r) are shown as the Pearson
index on training responsiveness (Δ).
No adverse effects associated with the intervention were
recorded, and no patient had to interrupt the intervention
or had their hospital stay modified because of it. ANCOVA
models revealed a significant group × time interaction in
handgrip strength (+2.5 kg), one repetition maximum
(1RM) chest press (+5.5 kg), short physical performance
battery score (+1.0), and gait speed (0.11 m/s) (all
P < 0.01) (Table 1). A total of 80 human proteins were
performed at Cytokine Array, and 59 were quantified with
the ImageQuant ECL system. The levels of five inflamma-
tory mediator cytokines differed between groups (Figure
1): MCP-3 and ENA-78 levels were higher in the exercise
group, whereas Insulin-like growth factor binding protein-4
(IGFBP-4), C-C motif chemokine 18 (PARC), and stem cell
factor (also known as SCF, KIT-ligand, KL, or SCF) levels
were lower. Correlation analysis of the full sample revealed
a negative relationship between ΔPARC levels and Δ1RM
chest press (r = 0.453, P = 0.011) and Δ1RM leg press
(r = 0.550, P < 0.001). Furthermore, a significant negative
correlation was observed between ΔSCF levels and 1RM
chest press (r = 0.399, P = 0.028) and Δhandgrip
strength/body weight (r = 0.343 P = 0.047) from baseline
to exercise.
© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders
LETTER TO THE EDITOR
Journal of Cachexia, Sarcopenia and Muscle 2020; 11: 1154–1157
Published online 8 June 2020 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/jcsm.12582
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the
original work is properly cited.
Discussion
Physical exercise training, tailored to the disease and to the
specific needs of the patient, has become a cornerstone of
modern therapeutic interventions for many chronic patholog-
ical conditions.5 A 3 day in-hospital intervention modifies the
serum levels of MCP-3 (increased), PARC (decreased), and
ENA-78 (increased), which are all essential to promote myo-
blast proliferation, physiological homing of mononuclear
blood cells, and inflammatory responses.6 Higher PARC levels
have recently been related to a higher degree of cardiac dys-
function and a lower exercise capacity.7 We also found that
IGFBP-4 and SCF levels were reduced after the in-hospital in-
tervention. Elevated plasma levels of SCF and its variants are
associated with inflammatory bowel disease and germ cell tu-
mours respectively, whereas IGFBP family members are
linked to breast, endometrial, colon, and skin cancers.6 Our
results might be a first important step to better understand
the potential role of inflammation in short-term adaptation
to 3 day in-hospital intervention.
Our findings shed new light on the development of in-
hospital strategies to prevent/reverse the functional
decline during acute hospitalization and for health status
monitoring.
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Table 1 Results of endpoints by group
Variable Exercise group Control group
Between-group
difference (95% CI) P-value
SPPB (balance, gait ability, leg strength), scorea 1.35 (2.23 to 0.46) 0.33 (1.33 to 0.66) 1.02 (0.20 to 2.24) 0.098
Handgrip strength, kg 1.51 (2.91 to 0.10) 0.99 (0.33 to 2.32) 2.50 (0.73 to 4.28) 0.007
Handgrip strength, kg/body weight, kg 0.01 (0.00 to 0.03) 0.02 (0.04 to 3.08) 0.04 (0.01 to 0.06) 0.013
Gait speed, m/s 0.11 (0.18 to 0.04) 0.01 (0.10 to 0.09) 0.10 (0.21 to 0.00) 0.061
1RM chest press, kg 3.63 (6.99 to 0.27) 1.91 (0.78 to 4.61) 5.55 (1.70 to 9.40) 0.006
1RM chest press, kg/body weight, kg 0.02 (0.01 to 0.06) 0.05 (0.10 to 0.01) 0.08 (0.03 to 0.14) <0.001
1RM leg press, kg 17.21 (22.44 to 11.97) 0.57 (11.05 to 12.20) 17.78 (7.80 to 27.76) <0.001
1RM leg press, kg/body weight, kg 0.26 (0.32 to 0.18) 0.005 (0.16 to 0.17) 0.29 (0.14 to 0.43) <0.001
Mini-Mental State Examination, scoreb 1.31 (2.69 to 0.06) 0.42 (2.26 to 1.40) 0.89 (1.10 to 2.88) 0.370
Barthel index (ADLs), scorec 3.00 (10.57 to 4.56) 1.34 (9.18 to 9.08) 3.00 (7.79 to 13.79) 0.577
Depression (GDS), scored 0.89 (0.08 to 1.87) 0.06 (1.16 to 1.03) 0.96 (2.26 to 0.34) 0.146
Abbreviations: 1RM, one repetition maximum; ADLs, activities of daily living; SPPB, Short Physical Performance Battery.
aThe SPPB scale ranges from 0 (worst) to 12 (best).
bThe Mini-Mental State Examination ranges from 0 (worst) to 30 (best).
cThe Barthel index ranges from 0 (severe functional dependence) to 100 (functional independence).
dThe Yesavage Geriatric Depression Scale ranges from 0 (best) to 15 (worst).
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FIGURE 1 (A–D) Hierarchical cluster analysis and cytokine response of significant variables with main effect time point and interaction effect at each
time point between exercised and control individuals using Ward’s method. Differences are represented by the computed relative treatment effect
(RTE). Red colour represents higher RTES, and green lower RTEs. *P < 0.05; P-value indicates significant interaction effects between group and time.
LIGAND for the receptor-type protein-tyrosine kinase KIT. ENA-78/CXCL5, C-X-C motif chemokine 5; IGFBP-4, IGF-binding proteins; MCP-3, monocyte
chemotactic protein 3; SCF/KITLG, kit ligand; PARC/CCL18, C-C motif chemokine 18.
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